PD patients exhibited a lower CSF p-tau level at motor onset than that of the controls and the mean annual changes in CSF p-tau was close to zero (0.06 pg/mL/year) and smaller than those in controls (0.31 pg/mL/year; Supplementary Fig. S1D). The gene discussed is MAPT; the disease is Parkinson disease.